creb3l3a Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
creb3l3a antibody; si:ch211-195b2 antibody; zgc:112279Cyclic AMP-responsive element-binding protein 3-like protein 3-A antibody; cAMP-responsive element-binding protein 3-like protein 3-A) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3-A] antibody
Target Names
creb3l3a
Uniprot No.

Target Background

Function
CREB3L3A is a transcriptional activator that binds to the cAMP response element (CRE). It activates transcription through the box-B element and CRE, and appears to function synergistically with ATF6. CREB3L3A regulates the transcription of FGF21.
Database Links

KEGG: dre:553700

UniGene: Dr.79847

Protein Families
BZIP family, ATF subfamily
Subcellular Location
Endoplasmic reticulum membrane; Single-pass type II membrane protein.; [Processed cyclic AMP-responsive element-binding protein 3-like protein 3-A]: Nucleus.

Q&A

What is CREB3L3, and what role does it play in cellular biology?

CREB3L3, also known as cyclic AMP-responsive element-binding protein 3-like protein 3, is a transcription factor primarily localized to the endoplasmic reticulum (ER). It plays a pivotal role in cellular stress management by activating genes involved in the unfolded protein response (UPR) and acute phase response during ER stress . CREB3L3 contains domains such as a leucine zipper and a basic leucine zipper (bZIP) that facilitate DNA binding and dimerization . Its functions extend to regulating hepatic metabolism, triglyceride levels, and inflammatory responses . Importantly, CREB3L3 has been implicated as a tumor suppressor in hepatocellular carcinoma (HCC), where its underexpression correlates with disease progression .

How is CREB3L3 antibody used in experimental studies?

CREB3L3 antibodies are employed in various experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHC-P), and enzyme-linked immunosorbent assay (ELISA) . These methods allow researchers to detect CREB3L3 protein in specific tissues or cell lines, quantify its expression levels, and study its interactions with other molecules. For instance, immunoprecipitation can be used to identify proteins that interact with CREB3L3, while WB provides quantitative data on its expression across different conditions .

What experimental controls are necessary when using CREB3L3 antibody?

To ensure the reliability of results, researchers must include appropriate controls when using CREB3L3 antibody. Negative controls, such as samples lacking the target protein or using isotype-matched non-specific antibodies, help confirm specificity. Positive controls, including samples known to express CREB3L3 at high levels (e.g., liver tissue under ER stress conditions), validate the antibody's efficacy . Additionally, loading controls like actin or tubulin are essential for normalization in WB experiments .

How does CREB3L3 regulate triglyceride metabolism?

CREB3L3 plays a critical role in maintaining normal plasma triglyceride concentrations by regulating the transcription of fibroblast growth factor 21 (FGF21) . FGF21 is a hormone that influences lipid metabolism and energy homeostasis. CREB3L3's activation during ER stress or cAMP stimulation leads to increased FGF21 expression, which subsequently modulates triglyceride levels . This regulatory pathway underscores CREB3L3's importance in metabolic health.

What are the structural features of CREB3L3 that enable its function?

CREB3L3 contains several key structural domains that facilitate its function as a transcription factor. These include a leucine zipper domain for dimerization and a basic leucine zipper (bZIP) domain for DNA binding . Additionally, its KDEL-like sequence ensures retention within the ER until activation. Upon activation by ER stress or cAMP signaling, CREB3L3 undergoes proteolytic cleavage and translocates to the nucleus to initiate transcription .

How does CREB3L3 contribute to hepatocellular carcinoma suppression?

CREB3L3 acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting AKT signaling pathways . Mechanistically, it competes with insulin receptor substrate 1 (IRS1) for binding to the insulin receptor (INSR), thereby reducing AKT phosphorylation and activity . This suppression of AKT signaling curtails cell proliferation and metastasis while promoting apoptosis in HCC cells . Furthermore, high expression levels of CREB3 are associated with better prognosis in HCC patients .

What challenges arise when interpreting data from CREB3L3 antibody experiments?

Researchers may encounter several challenges when interpreting data from CREB3L3 antibody experiments:

  • Cross-reactivity: Some antibodies may bind non-specifically to other proteins sharing homologous sequences.

  • Isoform specificity: CREB3L3 exists in multiple isoforms due to alternative splicing; antibodies may preferentially detect certain isoforms.

  • Experimental variability: Differences in sample preparation, antibody dilution, and detection methods can lead to inconsistent results.

  • Biological context: The functional state of CREB3L3 (e.g., active vs inactive) may influence its detectability .

Careful experimental design and validation are essential to mitigate these issues.

How can researchers study protein-protein interactions involving CREB3L3?

Protein-protein interactions involving CREB3L3 can be studied using co-immunoprecipitation (co-IP) assays followed by mass spectrometry or western blotting . For example, co-IP experiments have revealed that CREB3 interacts with INSR to regulate AKT signaling in HCC cells . Additionally, proximity ligation assays (PLA) can be employed for visualizing interactions at subcellular levels.

What role does ER stress play in activating CREB3L3?

ER stress triggers the activation of CREB3L3 through proteolytic cleavage mechanisms . Under stress conditions such as accumulation of misfolded proteins or lipid imbalances, CREB family members respond by initiating UPR pathways. For CREB3L3 specifically, this involves translocation from the ER to the nucleus where it binds DNA elements like cAMP response element (CRE) to activate target genes involved in stress mitigation .

How can researchers validate the specificity of a new anti-CREB3L antibody?

The specificity of a new anti-CREB antibody can be validated through several approaches:

  • Western blotting: Demonstrate exclusive detection of bands corresponding to expected molecular weights.

  • Immunoprecipitation: Confirm enrichment of target protein from cell lysates.

  • Knockdown/Knockout studies: Use RNA interference or CRISPR/Cas9 technology to eliminate target expression; absence of signal validates specificity.

  • Immunofluorescence: Show colocalization with known subcellular markers for the target protein.

  • Mass spectrometry: Identify peptides corresponding uniquely to the target protein following IP experiments .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.